| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in ELVN over the last quarter tilts toward selling: insiders offloaded a net 204,849 shares worth roughly $11.8M. In the past 30 days, 0 insiders bought and 3 sold. The bias lately has been to the sell side.
2 of the 3 insiders who sold still hold shares after their sales. Classified under Biotechnology (Health Care sector), ELVN's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 6.56M | $294.98M | - | |
| CEO | 890.4K | $19.43M | - | |
| Dir | 41.9K | $2.13M | - | |
| CFO | 38.0K | $564.3K | -6,018 | |
| Other | 25.0K | $62.0K | -5,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | Kunkel Lori Anne | Director | Sell10b5-1 | 10,000 | $50.49 | $504,903.25 | -19.3% | -9.1% | - | |
| Jun 22, 2026 | Orbimed Advisors LLC66 | 10% Owner | Sell | 860,123 | $45.36 | $39,014,045.60 | -11.6% | +6.3% | - | |
| Jun 17, 2026 | Hohl Benjamin59 | Chief Financial Officer | Sale+OE10b5-1 | 6,018 | $43.80 | $263,577.34 | -10.6% | +18.9% | - | |
| Jun 17, 2026 | Collins Helen Louise64 | Chief Medical Officer | Sale+OE10b5-1 | 5,000 | $43.80 | $219,016.84 | -16.7% | +18.9% | - | |
| Jun 15, 2026 | Orbimed Advisors LLC66 | 10% Owner | Sell | 281,408 | $45.02 | $12,668,988.16 | -3.7% | +28.5% | - | |
| Jun 5, 2026 | Kunkel Lori Anne | Director | Sell10b5-1 | 10,000 | $34.54 | $345,351.35 | -16.2% | +71.9% | - | |
| May 18, 2026 | Collins Helen Louise64 | Chief Medical Officer | Sale+OE10b5-1 | 5,000 | $39.79 | $198,971.39 | -16.7% | +50.2% | - | |
| Apr 17, 2026 | Collins Helen Louise64 | Chief Medical Officer | Sale+OE10b5-1 | 5,000 | $47.67 | $238,352.42 | -16.7% | +5.7% | - | |
| Mar 25, 2026 | Collins Helen Louise64 | Chief Medical Officer | Sale+OE10b5-1 | 40,000 | $35.10 | $1,404,024.00 | -61.5% | +36.8% | - | |
| Mar 17, 2026 | Collins Helen Louise64 | Chief Medical Officer | Sale+OE10b5-1 | 5,000 | $27.76 | $138,800.00 | -16.7% | +52.4% | - |